Starbucks
SBUX
$100.15
-0.50%
Starbucks Corp is the world's largest and most recognizable coffee brand, operating a global network of nearly 41,000 company-operated and licensed cafes across over 80 countries, and generating revenue from beverages, food, packaged goods, and ready-to-drink products. The company is a dominant market leader in the premium coffeehouse segment, distinguished by its powerful brand, massive global footprint, and a highly customizable beverage platform. The current investor narrative is intensely focused on the execution and early results of a major corporate turnaround strategy under CEO Brian Niccol, with recent headlines highlighting encouraging sales and profit growth momentum, cost-cutting initiatives like corporate layoffs, and a significant stock rally as the market assesses whether the operational recovery is sustainable.…
SBUX
Starbucks
$100.15
Related headlines
Investment Opinion: Should I buy SBUX Today?
Rating: Hold. The core thesis is that Starbucks is a high-risk, high-reward turnaround story where the market has already priced in a significant earnings recovery, leaving limited margin for error and creating an asymmetric risk/reward profile that favors caution. The analyst community reflects this with a mix of Buy and Hold ratings, and the implied target from forward EPS suggests upside, but only if execution is flawless.
The Hold rating is supported by four key data points: 1) The severe disconnect between the trailing P/E of 52.58x (premium) and depressed net margin of 2.96%, 2) The substantial 19-point gap between trailing and forward P/E (33.43x), which embeds massive earnings growth expectations, 3) The strong underlying cash generation ($2.34B FCF) that provides a financial safety net, and 4) The stock's position in the upper-mid range of its 52-week band, suggesting much of the near-term optimism is already priced in after a 19.86% YTD rally.
The two biggest risks invalidating a Hold are: 1) Further gross margin compression below 15%, signaling turnaround failure, and 2) Revenue growth decelerating below 3% YoY, indicating market share loss. This Hold would upgrade to a Buy if the forward P/E compressed below 25x (offering a better entry) alongside concrete evidence of margin expansion in the next quarterly report. It would downgrade to a Sell if the stock breaks below key support at $90 while margins continue to deteriorate. Relative to its history and sector peers, SBUX is overvalued on current fundamentals but may be fairly valued if the projected EPS of $5.08 is achieved.
Sign up to view all
SBUX 12-Month Price Forecast
The AI assessment is neutral based on a precarious risk/reward balance. The potential upside to analyst targets is significant (~68%), but it is entirely contingent on a dramatic earnings recovery that is not yet evident in the latest quarterly margins. The high valuation on current earnings means the stock is a 'show me' story. Confidence is medium because the company's powerful brand and cash flow provide a floor, but the path to margin restoration is unclear. The stance would upgrade to bullish on confirmation of sequential margin improvement in the next quarterly report. It would turn bearish if the stock breaks below $90 while fundamentals deteriorate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Starbucks's 12-month outlook, with a consensus price target around $130.20 and implied upside of +30.0% versus the current price.
Average Target
$130.20
11 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
11
covering this stock
Price Range
$80 - $130
Analyst target range
Analyst coverage for Starbucks is robust, with 11 analysts providing estimates, indicating strong institutional interest. The consensus sentiment leans cautiously optimistic, with a mix of Buy/Overweight and Hold ratings, as evidenced by recent actions from firms like Barclays (Overweight) and RBC Capital (downgrade to Sector Perform). The average target price implied by the estimated EPS of $5.08 and a forward PE of 33.43x is approximately $169.80, which would represent significant upside from the current price near $100, though a precise consensus target price is not provided in the data. The target range, inferred from estimated EPS, shows a low of $4.76 and a high of $5.35, reflecting a spread of about 12% around the average. The high target likely assumes successful turnaround execution leading to multiple expansion and earnings beats, while the low target may factor in persistent margin pressures or macroeconomic headwinds. Recent institutional rating actions show a pattern of stability with some caution, as seen in RBC Capital's March 2026 downgrade to Sector Perform from Outperform. The moderate spread in estimates signals a base level of conviction in the recovery narrative but also acknowledges the uncertainties surrounding cost initiatives and consumer demand.
Bulls vs Bears: SBUX Investment Factors
The investment debate for Starbucks centers on a high-stakes turnaround where bullish optimism about future earnings recovery clashes with bearish reality of current severe margin compression. The bull side currently has stronger narrative momentum, evidenced by the stock's YTD rally and analyst EPS targets implying significant upside. However, the bear side holds the stronger fundamental evidence, with profitability metrics at crisis levels and valuation stretched on current earnings. The single most important tension is whether CEO Brian Niccol's cost initiatives can successfully and swiftly restore margins to historical levels. If they can, the stock could re-rate higher on rising earnings. If they cannot, the elevated P/E multiple will contract sharply, exposing investors to substantial downside.
Bullish
- Strong Cash Flow Supports Turnaround: Despite margin pressures, Starbucks generated $2.34 billion in TTM free cash flow and $1.60 billion in operating cash flow last quarter. This robust cash generation provides the financial flexibility to fund dividends, service debt, and invest in the turnaround without liquidity concerns.
- Analyst EPS Growth Implies Major Upside: Analysts forecast average FY2026 EPS of $5.08, a massive recovery from the recent $0.26. Applying the forward P/E of 33.43x implies a target price near $170, representing over 68% upside from the current $100.65, signaling strong conviction in the earnings recovery narrative.
- Turnaround Momentum & Cost Initiatives: Recent news highlights encouraging early sales and profit growth under CEO Brian Niccol, with a strong earnings beat in late April 2026. The company is actively cutting costs, including laying off 300 corporate employees, to streamline operations and restore margins.
- Dominant Brand & Global Scale: As the world's largest coffee brand with nearly 41,000 stores across 80+ countries, Starbucks possesses unmatched scale and brand equity. This provides a durable competitive moat and a massive installed base from which to drive a recovery.
Bearish
- Severe Profitability & Margin Collapse: Q1 FY2026 net income plummeted 62% YoY to $293M, with gross margin collapsing from 24.49% to 15.63%. The net margin is a thin 2.96%, indicating the turnaround's success is far from guaranteed and current fundamentals are weak.
- Extremely Stretched Valuation on Current Earnings: The trailing P/E of 52.58x is near historical highs and a significant premium to the restaurant sector. This valuation prices in a perfect earnings recovery, leaving the stock vulnerable to multiple compression if execution falters.
- High Financial Leverage & Weak Liquidity: The balance sheet shows negative shareholder equity (Debt/Equity of -3.29) and a current ratio of 0.72, indicating potential liquidity constraints. The dividend payout ratio of 149% is unsustainable without a swift profit recovery.
- Decelerating Revenue Growth: Q1 revenue growth of 5.43% YoY represents a deceleration from stronger prior quarters. This suggests the business is in a stabilization, not high-growth, phase, making margin recovery the sole near-term catalyst.
SBUX Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 9.07% one-year price change, but is currently experiencing a near-term pullback from recent highs. As of the latest data, the price of $100.65 sits approximately 73% of the way up from its 52-week low of $77.99 towards its high of $108.88, indicating it is trading in the upper-mid range of its annual band, which suggests the stock retains positive momentum but may be consolidating after a strong run. Recent momentum shows a stark divergence: while the stock is up 8.75% over the last three months, it has declined 5.39% over the past month, signaling a deceleration and potential short-term profit-taking or reassessment of the rally's sustainability, especially as the stock underperformed the SPY by 6.13 percentage points over the same one-month period. Key technical support is anchored at the 52-week low of $77.99, while immediate overhead resistance is at the 52-week high of $108.88. A decisive breakout above $108.88 would signal a resumption of the bullish trend and potentially open the door to new highs, whereas a breakdown below the recent consolidation range could test lower support levels. The stock's beta of 0.977 indicates its volatility is nearly in line with the broader market, suggesting it is not an outsized source of systematic risk for a portfolio, though its recent 19.06% maximum drawdown highlights periods of meaningful price pressure that investors must be prepared to endure.
Beta
0.98
0.98x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$78-$109
Price range past year
Annual Return
+7.5%
Cumulative gain past year
| Period | SBUX Return | S&P 500 |
|---|---|---|
| 1m | -2.9% | -0.2% |
| 3m | +8.9% | +14.0% |
| 6m | +18.4% | +7.8% |
| 1y | +7.5% | +25.3% |
| ytd | +19.3% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SBUX Fundamental Analysis
Revenue growth has been positive but shows signs of pressure and volatility in profitability. The most recent Q1 FY2026 revenue was $9.91 billion, representing a 5.43% year-over-year increase, which is a deceleration from the stronger growth seen in prior quarters like Q1 FY2025. Segment data shows Beverage sales of $5.94 billion remain the core driver, but overall, the growth trajectory is modest as the company executes its turnaround. The revenue trend implies a business in a stabilization phase rather than high-growth mode, with the investment case hinging on margin recovery and operational efficiency gains. Profitability has been severely challenged, with net income in the latest quarter at $293 million, a sharp decline from $781 million in the year-ago quarter, and a gross margin of 15.63% that has compressed significantly from 24.49% a year prior. The net margin stands at a thin 2.96%, and operating margin is 9.18%, reflecting substantial cost pressures. While the company is profitable, the multi-quarter trend shows severe margin compression, putting the focus squarely on the success of cost-cutting initiatives and pricing strategies to restore historical profitability levels. The balance sheet shows a highly leveraged financial structure with a debt-to-equity ratio of -3.29 (indicating negative shareholder equity) and a current ratio of 0.72, which points to potential liquidity constraints. However, the company continues to generate substantial cash flow, with trailing twelve-month free cash flow of $2.34 billion and an operating cash flow of $1.60 billion in the latest quarter. This strong cash generation provides the financial flexibility to service debt, fund dividends (payout ratio of 149%), and invest in the business, mitigating some of the balance sheet risks despite the high leverage.
Quarterly Revenue
$9.9B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SBUX Overvalued?
Given that Net Income is positive ($293 million), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is elevated at 52.58x, while the forward PE is lower at 33.43x. This significant gap of over 19 points indicates the market is pricing in a substantial recovery in earnings over the next twelve months, banking on the success of the turnaround strategy to boost profitability from currently depressed levels. Compared to sector averages, Starbucks trades at a premium. Its trailing PE of 52.58x and forward PE of 33.43x are above typical restaurant industry averages, which often range in the low-to-mid 20s. Similarly, its Price-to-Sales ratio of 2.63x and EV/EBITDA of 22.50x are at the higher end for the sector. This premium is likely justified only if the company can successfully execute its turnaround and return to its historical high-margin, high-return profile; otherwise, the valuation appears stretched relative to current fundamentals. Historically, the current trailing PE of 52.58x is near the top of its own range over the past several quarters, which have seen PEs fluctuate from the low 20s to over 80x during periods of extreme earnings volatility. Trading near historical highs on a PE basis suggests the market has already priced in a significant earnings recovery and leaves little room for error. Investors are paying for expected future improvement, making the stock vulnerable to multiple compression if execution falters.
PE
52.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~184x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute and center on profitability and leverage. The gross margin collapse from 24.49% to 15.63% YoY is severe, and the net margin of 2.96% offers no buffer against further cost pressures. The balance sheet is highly leveraged with negative shareholder equity (D/E: -3.29) and weak short-term liquidity (Current Ratio: 0.72). While strong cash flow mitigates immediate solvency risk, the unsustainable 149% dividend payout ratio highlights the pressure to restore earnings. Execution risk on the turnaround is paramount; any delay in margin recovery could trigger a liquidity crunch or a dividend cut.
Market & Competitive Risks are elevated due to valuation and sector dynamics. Trading at a trailing P/E of 52.58x and forward P/E of 33.43x, SBUX carries a significant premium to the restaurant sector. This leaves it vulnerable to multiple compression if growth stalls or if sector-wide de-rating occurs. Its beta of 0.977 indicates market-correlated volatility, and the stock's 19.06% max drawdown shows it is not immune to sharp sell-offs. Competitively, while its brand is strong, the company faces pressure from both premium independents and value-focused chains, especially in a weakening consumer environment that could impact its 5.43% revenue growth.
Worst-Case Scenario involves a failed turnaround where cost initiatives fail to stem margin erosion, leading to consecutive earnings misses. This could trigger analyst downgrades, a dividend reduction, and a loss of investor confidence in the recovery narrative. The stock would likely de-rate towards its sector-average P/E in the low 20s on depressed earnings. A realistic downside target is the 52-week low of $77.99, representing a 22.5% decline from the current $100.65. In a severe bear market coupled with operational failure, the stock could test levels 30-35% below current prices as the premium valuation fully unwinds.
FAQ
The key risks are, in order of severity: 1) Operational: Failure of the turnaround to restore gross margins from 15.6% toward historical 20%+ levels, which would crush earnings projections. 2) Financial: High leverage with negative equity and weak liquidity (current ratio 0.72), increasing vulnerability to rising rates or a downturn. 3) Valuation: The premium trailing P/E of 52.58x leaves the stock exposed to severe multiple compression if growth disappoints. 4) Competitive/Macro: Decelerating 5.4% revenue growth could worsen in a consumer slowdown, pressuring the top line needed to fund the recovery.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees a gradual recovery, with a target range of $115-$125, driven by earnings meeting the $5.08 consensus. The Bull Case (30% probability) involves a successful turnaround, with targets of $169-$179 if margins recover and multiples expand. The Bear Case (20% probability) projects a drop to $78-$90 if the turnaround fails and the premium valuation contracts. The most likely outcome is the Base Case, predicated on the assumption that management's cost initiatives yield slow but steady margin improvement over the next year.
On current fundamentals, SBUX is significantly overvalued. A trailing P/E of 52.58x is difficult to justify with a net margin of just 2.96% and represents a large premium to the restaurant sector. However, the market is valuing future recovery, as shown by the lower forward P/E of 33.43x based on estimated EPS of $5.08. This implies the stock is fairly valued only if the company delivers on that aggressive earnings growth. Therefore, it is overvalued on today's numbers but could be fairly valued if the turnaround succeeds—making it a valuation-dependent story.
SBUX is a speculative buy, not a core holding. For investors who believe strongly in the turnaround and have a high risk tolerance, the potential 68% upside to analyst-implied targets is compelling. However, given the severe margin compression (gross margin down to 15.6%), high leverage (D/E of -3.29), and premium valuation (52.58x trailing P/E), it carries substantial risk. It is a better fit for tactical, turnaround-focused investors than for those seeking stability or income, as the 2.8% dividend yield is supported by an unsustainable 149% payout ratio.
SBUX is suitable only for a long-term investment horizon of 2-3 years minimum. The turnaround is a multi-quarter process, and the stock's high volatility (beta 0.98, 19.06% max drawdown) makes it a poor short-term trading vehicle. Investors need time for the margin recovery to materialize in earnings and for the valuation to normalize. The lack of near-term visibility and dependence on future earnings makes it unsuitable for short-term traders seeking quick gains. A long-term horizon allows investors to weather the inevitable volatility as the recovery story unfolds or fails.